Loading…
Protect Drinking Water from PFAS Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Protect Drinking Water from PFAS Act of 2021 This bill requires the Environmental Protection Agency (EPA) to address the level of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in drinking water. PFAS are man-made and may have adverse human health effects. A variety of products contain PFAS, such as nonstick cookware or weatherproof clothing. The EPA must publish a maximum contaminant level (MCL) and promulgate a national primary drinking water regulation for PFAS that includes perfluorooctanoic acid (commonly referred to as PFOA) and perfluorooctane sulfonic acid (commonly referred to PFOS). The MCL and regulation must be protective of the health of subpopulations that may be at greater risk than the general population of adverse health effects from exposure to PFAS in drinking water.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · first_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Read twice and referred to the Committee on Environment and Public Works.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $4,803,802 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $5,294,628 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $3,973,758 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Chemicals/Chemical Industry
Support public health protections in implementation of the Lautenberg Chemical Safety Act of 2016 Support measures to protect public health and the environment from toxic chemical hazards, including: H.R.2467 - PFAS Action Act of 2021 S.1334 - PFAS Accountability Act of 2021 H.R.4463 - PFAS Safe Disposal Act H.R.3990 /S.2047 - No PFAS in Cosmetics Act S.1121/ H.R.2742 - PFAS Registry Act of 2021 S.3169 / H.R.6026 - Keep Food Containers Safe from PFAS Act of 2021 H.R.4241/ S.1973 - PFAS Filthy Fifty Act S.2406 - Protect Drinking Water from PFAS Act of 2021 S.2555 /H.R.4340 - PFAS Exposure Assessment and Documentation Act H.R.5987 - PFAS Definition Improvement Act S.4244/H.R.7810 -- Alan Reinstein Ban Asbestos Now Act of 2022
Client expense: Not reported · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Chemicals/Chemical Industry
Support public health protections in implementation of the Lautenberg Chemical Safety Act of 2016 Support measures to protect public health and the environment from toxic chemical hazards, including: H.R.2467 - PFAS Action Act of 2021 S.1334 - PFAS Accountability Act of 2021 H.R.4463 - PFAS Safe Disposal Act H.R.3990 /S.2047 - No PFAS in Cosmetics Act S.1121/ H.R.2742 - PFAS Registry Act of 2021 S.3169 / H.R.6026 - Keep Food Containers Safe from PFAS Act of 2021 H.R.4241/ S.1973 - PFAS Filthy Fifty Act S.2406 - Protect Drinking Water from PFAS Act of 2021 S.2555 /H.R.4340 - PFAS Exposure Assessment and Documentation Act H.R.5987 - PFAS Definition Improvement Act S.4244/H.R.7810 -- Alan Reinstein Ban Asbestos Now Act of 2022
Client expense: $6,630 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Chemicals/Chemical Industry
Support public health protections in implementation of the Lautenberg Chemical Safety Act of 2016 Support measures to protect public health and the environment from toxic chemical hazards, including: H.R.2467 - PFAS Action Act of 2021 S.1334 - PFAS Accountability Act of 2021 H.R.4463 - PFAS Safe Disposal Act H.R.3990 /S.2047 - No PFAS in Cosmetics Act S.1121/ H.R.2742 - PFAS Registry Act of 2021 S.3169 / H.R.6026 - Keep Food Containers Safe from PFAS Act of 2021 H.R.4241/ S.1973 - PFAS Filthy Fifty Act S.2406 - Protect Drinking Water from PFAS Act of 2021 S.2555 /H.R.4340 - PFAS Exposure Assessment and Documentation Act H.R.5987 - PFAS Definition Improvement Act S.4244/H.R.7810 -- Alan Reinstein Ban Asbestos Now Act of 2022
Client expense: $6,298 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Chemicals/Chemical Industry
Support public health protections in implementation of the Lautenberg Chemical Safety Act of 2016 Support measures to protect public health and the environment from toxic chemical hazards, including: H.R.2467 - PFAS Action Act of 2021 S.1334 - PFAS Accountability Act of 2021 H.R.4463 - PFAS Safe Disposal Act H.R.3990 /S.2047 - No PFAS in Cosmetics Act S.1121/ H.R.2742 - PFAS Registry Act of 2021 S.3169 / H.R.6026 - Keep Food Containers Safe from PFAS Act of 2021 H.R.4241/ S.1973 - PFAS Filthy Fifty Act S.2406 - Protect Drinking Water from PFAS Act of 2021 S.2555 /H.R.4340 - PFAS Exposure Assessment and Documentation Act
Client expense: Not reported · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Chemicals/Chemical Industry
Support public health protections in implementation of the Lautenberg Chemical Safety Act of 2016 Support measures to protect public health and the environment from toxic chemical hazards, including: H.R.2467 - PFAS Action Act of 2021 S.1334 - PFAS Accountability Act of 2021 H.R.4463 - PFAS Safe Disposal Act H.R.3990 /S.2047 - No PFAS in Cosmetics Act S.1121/ H.R.2742 - PFAS Registry Act of 2021 H.R.4241/ S.1973 - PFAS Filthy Fifty Act S.2406 - Protect Drinking Water from PFAS Act of 2021 S.2555 /H.R.4340 - PFAS Exposure Assessment and Documentation Act H.R.4350/S.2792 -- National Defense Authorization Act for Fiscal Year 2022
Client expense: Not reported · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Chemicals/Chemical Industry
Support public health protections in implementation of the Lautenberg Chemical Safety Act of 2016 Support measures to protect public health and the environment from toxic chemical hazards, including: H.R.2467 - PFAS Action Act of 2021 S.1334 - PFAS Accountability Act of 2021 H.R.4463 - PFAS Safe Disposal Act H.R.3990 /S.2047 - No PFAS in Cosmetics Act S.1121/ H.R.2742 - PFAS Registry Act of 2021 S.3169 / H.R.6026 - Keep Food Containers Safe from PFAS Act of 2021 H.R.4241/ S.1973 - PFAS Filthy Fifty Act S.2406 - Protect Drinking Water from PFAS Act of 2021 S.2555 /H.R.4340 - PFAS Exposure Assessment and Documentation Act H.R.4350/S.2792 -- National Defense Authorization Act for Fiscal Year 2022
Client expense: $5,878 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| CT |